MARKET

VBIV

VBIV

VBI Vaccines
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.090
+0.110
+3.69%
After Hours: 3.120 +0.03 +0.97% 19:43 03/05 EST
OPEN
3.060
PREV CLOSE
2.980
HIGH
3.100
LOW
2.680
VOLUME
6.63M
TURNOVER
--
52 WEEK HIGH
6.93
52 WEEK LOW
0.6900
MARKET CAP
784.87M
P/E (TTM)
-14.9348
1D
5D
1M
3M
1Y
5Y
Canaccord Genuity Sticks to Their Buy Rating for VBI Vaccines (VBIV)
SmarterAnalyst · 2d ago
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
Zacks.com · 3d ago
VBI Vaccines Stock Could Blast Higher by 170%, Says Analyst
Several small-cap biotech firms have used the coronavirus as a springboard, and since the pandemic’s onset many have become almost household names. Despite making meaningful market strides over the past year, VBI Vaccines (VBIV) is not one that immediately...
TipRanks · 3d ago
8-K: VBI Vaccines Inc/BC
(EDGAR Online via COMTEX) -- 0000764195 false VBI Vaccines Inc/BC 0000764195 2021-03-02 2021-03-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 3d ago
VBI Vaccines EPS misses by $0.15, misses on revenue
VBI Vaccines (VBIV): Q4 GAAP EPS of -$0.21 misses by $0.15.Revenue of $0.2M (-66.7% Y/Y) misses by $0.21M.Shares -6.77%.Press Release
Seekingalpha · 3d ago
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of 0.00% and -62.73%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 3d ago
BRIEF-VBI Vaccines Reports Q4 And Full Year Financial Results For 2020
reuters.com · 3d ago
VBI Vaccines FY20 EPS $(0.21) vs $(0.46) In FY19
VBI Vaccines (NASDAQ:VBIV) will report on Q4 2020.
Benzinga · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VBIV. Analyze the recent business situations of VBI Vaccines through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VBIV stock price target is 6.60 with a high estimate of 9.00 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 178
Institutional Holdings: 133.06M
% Owned: 54.97%
Shares Outstanding: 254.00M
TypeInstitutionsShares
Increased
48
8.01M
New
54
-10.91M
Decreased
25
2.73M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.94%
Pharmaceuticals & Medical Research
+1.63%
Key Executives
Chairman/Independent Director
Steven Gillis
President/Chief Executive Officer/Director
Jeffrey Baxter
Chief Financial Officer/Director
Christopher McNulty
Chief Scientific Officer
David Anderson
General Manager
Avi Mazaltov
Other
Nell Beattie
Other
Francisco Diaz-Mitoma
Independent Director
Damian Braga
Independent Director
Joanne Cordeiro
Independent Director
Blaine Mckee
Independent Director
Michel Wilde
No Data
About VBIV
VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

Webull offers kinds of VBI Vaccines Inc stock information, including NASDAQ:VBIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VBIV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VBIV stock methods without spending real money on the virtual paper trading platform.